Clinical Trial Management System (CTMS) Market by Deployment, End-user and Geography - Forecast and Analysis 2023-2027

Published: Feb 2023 Pages: 160 SKU: IRTNTR43269

The clinical trial management system (CTMS) market is estimated to grow at a CAGR of 12.81% between 2022 and 2027. The size of the market is forecast to increase by USD 1,449.16 million. The growth of the market depends on several factors, including the increasing healthcare expenditure, the rise in clinical trials for drugs, and the increased adoption of CTMS.

This report extensively covers market segmentation by deployment (on-premise and cloud), end-user (pharmaceutical and biotechnology companies, CROs, and others), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Clinical trial Management System (CTMS) Market During the Forecast Period?

To learn more about this report, Download Report Sample

Parent Market Analysis

Technavio categorizes the global clinical trial management system (CTMS) market as a part of the global healthcare technology, which, in turn, is a part of the global healthcare market. The market includes the revenue generated from the sales of healthcare applications and IT systems, Internet-based healthcare tools (such as monitoring devices), and IT consulting services to clinics, hospitals, or businesses operating primarily in the healthcare sector. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.

Clinical trial Management System (CTMS) Market: Key Drivers, Trends, Challenges, and Customer Landscape

The increasing healthcare expenditure is notably driving the market growth, although factors such as the rising cost of clinical trials may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Clinical trial Management System (CTMS) Market Driver

Increasing healthcare expenditure is the major driver fueling the clinical trial management system market growth. With the increasing prevalence of chronic diseases and the rising disposable incomes of people around the world, healthcare expenditure is increasing. For the management of highly critical clinical trials, doctors may use CTMS. Moreover, the growing awareness about the need for early diagnosis, as well as the risks of negligence in seeking timely medical help, is making people health-conscious, which, in turn, is leading to an increase in their healthcare expenditure. Healthcare expenditure in most developed countries is higher than that in the rest of the world.

However, emerging markets, such as China, India, and Brazil, are witnessing an increase in healthcare spending due to the rising disposable incomes of the people. Therefore, increasing healthcare expenditure is expected to drive the growth of the global CTMS market during the forecast period.

Significant Clinical trial Management System (CTMS) Market Trend

Integration of CTMS with other systems is the major trend influencing the clinical trial management system market growth. There is considerable overlap between CTMS and other systems, which results in a high degree of integration. Because of integration, the information can be passed electronically between systems, making it more rapidly available wherever needed, while avoiding transcription errors. Further, this integration is possible because of access to the Internet, which enables widespread access to CTMS through web browsers. Internet results in the reality of devolution of CTMS access to a wider community of more occasional users. Currently, CTMS integrates with hospital systems to obtain data on patient demographics and laboratory data for patients participating in clinical trials. There is also an opportunity for data to flow from a CTMS to an electronic medical record (EMR) to help with both patient billing and patient safety.

Moreover, patient safety can be better served when healthcare providers can use the EMR to recognize that their patient is registered for a clinical trial. Similarly, the availability of the latest billing grid information from the CTMS to inform patients helps ensure Medicare or Medicaid billing compliance. Hence, this eliminates the need to re-enter this data into a CTMS, thereby preventing data copy errors. Hence, a link between EMR and clinical trial research improves data collection and processing. Further, with the trend of e-systems, the opportunities for integration with other systems will increase, thereby boosting the market growth during the forecast period.

Major Clinical trial Management System (CTMS) Market Challenge

The rising cost of clinical trials is a major hindrance to the clinical trial management system market growth. Clinical trial management has changed dramatically over the years, and the rising costs of clinical trials are a concern. The cost of clinical trials increases because of many factors. For instance, drugs undergo a difficult and slow process during clinical trials. The initial difficulty is patient enrolment, which is followed by making sure patients continue the trial and do not drop out of the research study. A second factor that contributes to the rising costs is the increasing need to collect more clinical data.

Newer regulations stipulate more thorough and prolonged safety testing during clinical trials. As a result, clinical trials, especially for drugs attempting to alleviate chronic diseases, tend to be complex and sometimes prohibitively expensive. Thus, the longer the trial goes on for the abovementioned issues, the costs keep increasing, and clinical research associates (CRAs) will avoid the management systems and prefer manual work for cost-cutting in trial research, thus hindering market growth.

Key Clinical trial Management System (CTMS) Market Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Clinical trial Management System (CTMS) Market Customer Landscape

Who are the Major Clinical trial Management System (CTMS) Market Vendors?

Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Advarra Inc.: The company offers a clinical trial management system namely Clinical Conductor CTMS.

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:

  • ArisGlobal LLC
  • eResearchTechnology GmbH
  • Dassault Systemes SE
  • DATATRAK International Inc.
  • International Business Machines Corp.
  • Medpace Holdings Inc.
  • Oracle Corp.
  • Parexel International Corp.
  • Veeva Systems Inc.
  • Laboratory Corp. of America Holdings
  • DSG Inc.
  • MasterControl Inc.
  • Wipro Ltd.
  • MedNet
  • Medfiles USA

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Clinical trial Management System (CTMS) Market?

The market share growth by the On-premise segment will be significant during the forecast period. In this segment, owning and maintaining a server increases the perceived level of data security. Hence, large firms with enough resources are less likely to shift to other solutions. Siebel and IMPACT are on-premises CTMS majorly available in the market. Thus, such factors are expected to drive the growth of the segment in the global CTMS market during the forecast period.

Get a glance at the market contribution of various segments Request a PDF Sample

The on-premise segment was valued at USD 648.20 million in 2017 and continue to grow by 2021. CTMS, generally deployed on-premises, provides better data security with high control compared with that of cloud-based deployment. However, the on-premises model requires large investments in infrastructure. Moreover, owing to the high cost associated with its maintenance, firms are looking for an alternative solution. Such factors are expected to hamper the CTMS demand in the global CTMS market during the forecast period.

Which are the Key Regions for the Clinical trial Management System (CTMS) Market?

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Factors such as ease of the regulatory process, a high number of pharmaceutical and biotechnology companies and CROs in the region, and considerable investments in clinical trial research, which will increase the CTMS market in North America at a significant pace in the global market during the forecast period. The major revenue-contributing countries in North America include the US, followed by Canada and Mexico. There has been an increase in the number of clinical trials in these countries, which increased the demand for CTMS in recent years, 2020-2022. As clinical trials are conducted with ease in these economies, along with increased research in leading countries such as the US and Canada, the CTMS market is likely to witness growth in the region.

The increasing prevalence of COVID-19 was also one of the key factors driving the demand for CTMS software in the region. However, the lifting of the lockdowns in the first half of 2021 owing to the initiation of vaccination drives across North America resulted in the resumption of operations in these end-user industries, such as big pharma, CROs and others which will increase the demand for CTMSs during the forecast period. Hence, the CTMS market in North America will witness growth during the forecast period.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Deployment Outlook (USD Million, 2017 - 2027)
    • On-premise
    • Cloud
  • End-user Outlook (USD Million, 2017 - 2027)
    • Pharmaceutical and biotechnology companies
    • CROs
    • Others
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Argentina
      • Australia
      • Rest of the world

Clinical trial Management System (CTMS) Market Scope

Report Coverage

Details

Page number

160

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.81%

Market growth 2023-2027

USD 1,449.16 million

Market structure

Fragmented

YoY growth 2022-2023(%)

12.06

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key countries

US, Canada, Germany, UK, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

ArisGlobal LLC, eResearchTechnology GmbH, Advarra Inc., Dassault Systemes SE, DATATRAK International Inc., International Business Machines Corp., Medpace Holdings Inc., Oracle Corp., Parexel International Corp., Veeva Systems Inc., Laboratory Corp. of America Holdings, DSG Inc., MasterControl Inc., Wipro Ltd., MedNet, Medfiles USA, Crucial Data Solutions Inc., Ennov SAS, RealTime Software Solutions LLC, and PHARMASEAL

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Clinical trial Management System (CTMS) Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the clinical trial management system (CTMS) market between 2023 and 2027
  • Precise estimation of the clinical trial management system (CTMS) market size and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of clinical trial management system (CTMS) market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Deployment
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global clinical trail management system (CTMS) market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global clinical trail management system (CTMS) market 2017 - 2021 ($ million)
    • 4.2 Deployment Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Deployment Segment 2017 - 2021 ($ million)
    • 4.3 End-user Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Deployment

    • 6.1 Market segments
      • Exhibit 30: Chart on Deployment - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Deployment - Market share 2022-2027 (%)
    • 6.2 Comparison by Deployment
      • Exhibit 32: Chart on Comparison by Deployment
      • Exhibit 33: Data Table on Comparison by Deployment
    • 6.3 On-premise - Market size and forecast 2022-2027
      • Exhibit 34: Chart on On-premise - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on On-premise - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on On-premise - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on On-premise - Year-over-year growth 2022-2027 (%)
    • 6.4 Cloud - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Cloud - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Cloud - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Cloud - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Cloud - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Deployment
      • Exhibit 42: Market opportunity by Deployment ($ million)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
    • 7.2 Comparison by End-user
      • Exhibit 45: Chart on Comparison by End-user
      • Exhibit 46: Data Table on Comparison by End-user
    • 7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
    • 7.4 CROs - Market size and forecast 2022-2027
      • Exhibit 51: Chart on CROs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on CROs - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on CROs - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on CROs - Year-over-year growth 2022-2027 (%)
    • 7.5 Others - Market size and forecast 2022-2027
      • Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 59: Market opportunity by End-user ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 63: Chart on Geographic comparison
      • Exhibit 64: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 89: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 UK - Market size and forecast 2022-2027
      • Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 101: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 104: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 105: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 106: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 107: Matrix on vendor position and classification
            • 12.3 Advarra Inc.
              • Exhibit 108: Advarra Inc. - Overview
              • Exhibit 109: Advarra Inc. - Product / Service
              • Exhibit 110: Advarra Inc. - Key offerings
            • 12.4 ArisGlobal LLC
              • Exhibit 111: ArisGlobal LLC - Overview
              • Exhibit 112: ArisGlobal LLC - Product / Service
              • Exhibit 113: ArisGlobal LLC - Key offerings
            • 12.5 Dassault Systemes SE
              • Exhibit 114: Dassault Systemes SE - Overview
              • Exhibit 115: Dassault Systemes SE - Product / Service
              • Exhibit 116: Dassault Systemes SE - Key news
              • Exhibit 117: Dassault Systemes SE - Key offerings
            • 12.6 DATATRAK International Inc.
              • Exhibit 118: DATATRAK International Inc. - Overview
              • Exhibit 119: DATATRAK International Inc. - Product / Service
              • Exhibit 120: DATATRAK International Inc. - Key news
              • Exhibit 121: DATATRAK International Inc. - Key offerings
            • 12.7 DSG Inc.
              • Exhibit 122: DSG Inc. - Overview
              • Exhibit 123: DSG Inc. - Product / Service
              • Exhibit 124: DSG Inc. - Key offerings
            • 12.8 eResearchTechnology GmbH
              • Exhibit 125: eResearchTechnology GmbH - Overview
              • Exhibit 126: eResearchTechnology GmbH - Product / Service
              • Exhibit 127: eResearchTechnology GmbH - Key offerings
            • 12.9 International Business Machines Corp.
              • Exhibit 128: International Business Machines Corp. - Overview
              • Exhibit 129: International Business Machines Corp. - Business segments
              • Exhibit 130: International Business Machines Corp. - Key offerings
              • Exhibit 131: International Business Machines Corp. - Segment focus
            • 12.10 Laboratory Corp. of America Holdings
              • Exhibit 132: Laboratory Corp. of America Holdings - Overview
              • Exhibit 133: Laboratory Corp. of America Holdings - Business segments
              • Exhibit 134: Laboratory Corp. of America Holdings - Key news
              • Exhibit 135: Laboratory Corp. of America Holdings - Key offerings
              • Exhibit 136: Laboratory Corp. of America Holdings - Segment focus
            • 12.11 MasterControl Inc.
              • Exhibit 137: MasterControl Inc. - Overview
              • Exhibit 138: MasterControl Inc. - Product / Service
              • Exhibit 139: MasterControl Inc. - Key offerings
            • 12.12 MedNet
              • Exhibit 140: MedNet - Overview
              • Exhibit 141: MedNet - Product / Service
              • Exhibit 142: MedNet - Key offerings
            • 12.13 Medpace Holdings Inc.
              • Exhibit 143: Medpace Holdings Inc. - Overview
              • Exhibit 144: Medpace Holdings Inc. - Product / Service
              • Exhibit 145: Medpace Holdings Inc. - Key offerings
            • 12.14 Oracle Corp.
              • Exhibit 146: Oracle Corp. - Overview
              • Exhibit 147: Oracle Corp. - Business segments
              • Exhibit 148: Oracle Corp. - Key news
              • Exhibit 149: Oracle Corp. - Key offerings
              • Exhibit 150: Oracle Corp. - Segment focus
            • 12.15 Parexel International Corp.
              • Exhibit 151: Parexel International Corp. - Overview
              • Exhibit 152: Parexel International Corp. - Product / Service
              • Exhibit 153: Parexel International Corp. - Key news
              • Exhibit 154: Parexel International Corp. - Key offerings
            • 12.16 Veeva Systems Inc.
              • Exhibit 155: Veeva Systems Inc. - Overview
              • Exhibit 156: Veeva Systems Inc. - Business segments
              • Exhibit 157: Veeva Systems Inc. - Key offerings
              • Exhibit 158: Veeva Systems Inc. - Segment focus
            • 12.17 Wipro Ltd.
              • Exhibit 159: Wipro Ltd. - Overview
              • Exhibit 160: Wipro Ltd. - Business segments
              • Exhibit 161: Wipro Ltd. - Key news
              • Exhibit 162: Wipro Ltd. - Key offerings
              • Exhibit 163: Wipro Ltd. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 164: Inclusions checklist
                • Exhibit 165: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 166: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 167: Research methodology
                • Exhibit 168: Validation techniques employed for market sizing
                • Exhibit 169: Information sources
              • 13.5 List of abbreviations
                • Exhibit 170: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              clinical trail management system (ctms) market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis